Assessment of Safety and Satisfaction Toward COVID-19 Vaccines.
NCT05857176 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 508
Last updated 2023-05-23
Summary
This is a cross-sectional, web-based online survey done with the use of a Google Form-questionnaire to gather information from the general public regarding their knowledge, satisfaction, and tolerability about the COVID-19 vaccine.
Conditions
- COVID-19 Vaccine Adverse Reaction
Interventions
- OTHER
-
COVID-19 Vaccine questionnaire
An online questionnaire, designed on Google Forms, was written in Arabic language and delivered to participants via social media (primarily Facebook, WhatsApp and Linkedin).
Sponsors & Collaborators
-
Alexandria University
collaborator OTHER -
Damanhour University
lead OTHER
Principal Investigators
-
Rehab H Werida, Ass. Prof. · Damanhour University
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-12-15
- Primary Completion
- 2022-02-01
- Completion
- 2022-02-10
Countries
- Egypt
Study Locations
More Related Trials
-
Safety and Immunogenicity Study of EgyVax Vaccine Candidate for Prophylaxis of COVID-19 Infection
NCT05218070 ·Status: UNKNOWN ·Phase: PHASE1
-
A Study to Evaluate the Efficacy, Safety, and Immunogenicity of SARS-CoV-2 Variant (BA.4 /5) mRNA Vaccine
NCT05636319 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
A Phase I Safty and Immunogenicity Study of SCT1000 in Healthy Women Aged 18 to 45 Years
NCT04921111 ·Status: UNKNOWN ·Phase: PHASE1
-
Study of the Safety, Reactogenicity and Immunogenicity of "EpiVacCorona" Vaccine for the Prevention of COVID-19
NCT04527575 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Randomized Trial of COVID-19 Booster Vaccinations (Cobovax Study)
NCT05057169 ·Status: COMPLETED ·Phase: PHASE4
-
Adolescents Seeking COVID Vaccination (Teen COVID Vax)
NCT05537103 ·Status: COMPLETED
-
Immunogenicity and Safety Study of 2 Doses of Live Attenuated Varicella Vaccine
NCT01817270 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Immunogenicity Study of AdCLD-CoV19-1: A COVID-19 Preventive Vaccine in Healthy Volunteers
NCT05047692 ·Status: COMPLETED ·Phase: PHASE1
-
Comparative Study of Patterns of Immune Response to COVID 19 Vaccination
NCT05408299 ·Status: UNKNOWN
-
A Global Phase III Clinical Trial of Recombinant COVID- 19 Vaccine (Sf9 Cells)
NCT04904471 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Immunogenicity of AdCLD-CoV19-1 OMI as a Booster: A SARS-CoV-2 (COVID-19) Preventive Vaccine
NCT05576623 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Efficacy and Safety of COVID-19 Vaccine as Booster Vaccination in Adults 18 Years of Age or Older
NCT05683600 ·Status: TERMINATED ·Phase: PHASE3
-
Reactogenicity, Safety and Immunogenicity of QazCoVac-P COVID-19 Vaccine
NCT04930003 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Phase 3 Booster Vaccination Against COVID-19
NCT05077176 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Safety, Immunogenicity, and Efficacy of UB-612 COVID-19 Vaccine
NCT04683224 ·Status: WITHDRAWN ·Phase: PHASE2/PHASE3
-
An Effectiveness Study of the Sinovac's Adsorbed COVID-19 (Inactivated) Vaccine
NCT04747821 ·Status: COMPLETED ·Phase: PHASE4
-
Immunization of 7 Different Vaccines Against SARS-COV-2 Across 4 Countries.
NCT05228912 ·Status: COMPLETED
-
A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age
NCT07300839 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Study to Assess Safety, Reactogenicity and Immunogenicity of the repRNA(QTP104) Vaccine Against SARS-CoV-2(COVID-19)
NCT05876364 ·Status: UNKNOWN ·Phase: PHASE1
-
Post-Vaccination Biological Collection
NCT03875703 ·Status: RECRUITING
-
The Study of "Gam-COVID-Vac" Vaccine Against COVID-19 With the Participation of Volunteers of 60 y.o and Older
NCT04587219 ·Status: UNKNOWN ·Phase: PHASE2
-
Effectiveness of the Adsorbed Vaccine COVID-19 (Coronavac) Among Education and Public Safety Workers With Risk Factors for Severity
NCT04789356 ·Status: UNKNOWN ·Phase: PHASE4
-
Study on the Epidemiological Characteristics of Female HPV Vaccination in China
NCT05932563 ·Status: UNKNOWN
-
Effectiveness, Immunogenicity and Safety of the Second Booster Dose of the Vaccine Against COVID-19 in the Elderly
NCT05283902 ·Status: COMPLETED
-
A Phase III Study of COVID-19 Vaccine EuCorVac-19 in Healthy Adults
NCT05572879 ·Status: COMPLETED ·Phase: PHASE3